Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Response

Federica Bertolini et. al., Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance

  • Response

Pierina Navarria et. al., Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series

  • Response

Francesca Spada et. al., Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

  • Myriapod NGS, Response

Francesca Consoli et. al., A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report

  • Response

Girolamo Crisi et. al., Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach

  • Response

Özlem Aydemir et. al., Servikal örneklerde human papillomavirüs pozitifli?i ve genotip da??l?m?

  • Response

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients with disease progression to standard chemotherapy plus mitotane

  • Response

Florencia W Djigma et. al., Molecular Genotyping of Human Papillomavirus among HIV-infected and HIV-uninfected Women in Ouagadougou, Burkina Faso.

Your next step starts here. Fill out the form and talk to us

Let's talk
Subscribe to Our Newsletter
logo Diatech Pharmacogenetics

Subscribe to Our Newsletter